ArticleJournal of magnetic resonance imaging : JMRI2026
Hemodynamic Mechanisms in Venous Pulsatile Tinnitus: A 4D Flow MRI Analysis of Transverse-Sigmoid Sinus Abnormalities.
Article in Journal of magnetic resonance imaging : JMRI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial for "Hemodynamic Mechanisms in Venous Pulsatile Tinnitus: A 4D Flow MRI Analysis of Transverse-Sigmoid Sinus Abnormalities".Journal of magnetic resonance imaging : JMRI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundVenous pulsatile tinnitus (VPT) is associated with transverse-sigmoid sinus (TSS) anomalies, bone dehiscence (BD), and hemodynamic disturbances. 4D Flow MRI enables comprehensive TSS evaluation, but causal relationships among TSS morphology, hemodynamics, and BD in VPT onset and progression remain unquantified. Reliable imaging predictors for VPT progression and BD's mediating role are unestablished. PURPOSE: To construct a directed acyclic graph (DAG) testing whether stenosis-induced hemodynamic abnormalities and bone changes predict VPT occurrence and 6-month progression. STUDY TYPE: Prospective longitudinal cohort study. POPULATION: 126 unilateral VPT patients (36 [31-44] years; 73.0% female) and 83 matched non-VPT participants (35 [28-42] years; 71.1% female); all VPT patients completed 6-month symptom follow-up. FIELD STRENGTH/SEQUENCE: 3 T multi-shot turbo field echo 4D Flow MRI and fast field echo phase-contrast MR venography (PC MRV). ASSESSMENT: Three blinded neuroradiologists independently assessed TSS morphology, hemodynamic indices, and petrous BD using PC MRV, 4D Flow MRI, and high-resolution CT multiplanar reconstruction. Interobserver reliability was evaluated with discrepancies resolved by consensus. STATISTICAL TESTS: Kolmogorov-Smirnov, Chi-Square, Mann-Whitney U test, FDR-corrected correlation analysis, linear/logistic regression, mediation analysis, and ROC curve analysis. SIGNIFICANCE: p < 0.05.
results74.6% of VPT patients had 6-month progression (increased Tinnitus Handicap Inventory, THI score vs. baseline). Peak flow velocity (38.79 cm/s cut-off) independently predicted 6-month progression (area under the curve, AUC = 0.840; 95% confidence interval, CI: 0.755-0.925). TSS stenosis combined with hemodynamic parameters predicted VPT occurrence (AUC = 0.895, 95% CI: 0.855-0.936). Mediation analysis confirmed BD mediated the effect of wall shear stress on THI. Hierarchical causal pathways among TSS morphology, hemodynamics, BD, and VPT were identified to verify quantifiable DAG. DATA
conclusionTSS stenosis initiates hemodynamic disturbances and bone changes, which collectively drive VPT occurrence and 6-month progression. Integrating these morphological and hemodynamic parameters yields accurate predictive models. EVIDENCE LEVEL: 4. TECHNICAL EFFICACY: Stage 3.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.